Related Experiment Video
Updated: Jul 19, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals
Peter Scott1, Hong Ma, Suganya Viriyakosol
1Veterans Affairs Medical Center, Department of Medicine, University of California-San Diego, San Diego, CA 92161, USA.
Abstract:
Phagocyte ingestion of monosodium urate (MSU) crystals can induce proinflammatory responses and trigger acute gouty inflammation. Alternatively, the uptake of MSU crystals by mature macrophages can be noninflammatory and promote resolution of gouty inflammation. Macrophage activation by extracellular MSU crystals involves apparent recognition and ingestion mediated by TLR2 and TLR4, with subsequent intracellular recognition linked to caspase-1 activation and IL-1beta processing driven by the NACHT-LRR-PYD-containing protein-3 inflammasome. In this study, we examined the potential role in gouty inflammation of CD14, a phagocyte-expressed pattern recognition receptor that functionally interacts with both TLR2 and TLR4. MSU crystals, but not latex beads, directly bound recombinant soluble (s) CD14 in vitro. CD14(-/-) bone marrow-derived macrophages (BMDMs) demonstrated unimpaired phagocytosis of MSU crystals but reduced p38 phosphorylation and approximately 90% less IL-1beta and CXCL1 release. Attenuated MSU crystal-induced IL-1beta release in CD14(-/-) BMDMs was mediated by decreased pro-IL-1beta protein expression and additionally by decreased caspase-1 activation and IL-1beta processing consistent with diminished NACHT-LRR-PYD-containing protein-3 inflammasome activation. Coating of MSU crystals with sCD14, but not sTLR2 or sTLR4, restored IL-1beta and CXCL1 production in CD14(-/-) BMDMs in vitro. Gain of function of CD14 directly enhanced TLR4-mediated signaling in response to MSU crystals in transfected Chinese hamster ovary cells in vitro. Last, MSU crystal-induced leukocyte influx at 6 h was reduced by approximately 75%, and local induction of IL-1beta decreased by >80% in CD14(-/-) mouse s.c. air pouches in vivo. We conclude that engagement of CD14 is a central determinant of the inflammatory potential of MSU crystals.
Insights
CD14 engagement is key in monosodium urate (MSU) crystal-induced gouty inflammation. Blocking CD14 significantly reduces IL-1beta release and leukocyte influx, highlighting its central role in the inflammatory response.
Area of Science:
- Immunology
- Inflammation Research
- Crystal-Induced Arthritis
Background:
- Phagocyte ingestion of monosodium urate (MSU) crystals triggers gouty inflammation.
- Macrophage activation involves TLR2/TLR4, caspase-1, and the NLRP3 inflammasome.
- CD14 is a pattern recognition receptor interacting with TLR2 and TLR4.
Purpose of the Study:
- To investigate the role of CD14 in MSU crystal-induced gouty inflammation.
- To determine if CD14 influences MSU crystal recognition, phagocytosis, and subsequent inflammatory signaling.
Main Methods:
- In vitro binding assays with soluble CD14 (sCD14) and MSU crystals.
- Macrophage phagocytosis assays using CD14(-/-) bone marrow-derived macrophages (BMDMs).
- Analysis of inflammatory mediator release (IL-1beta, CXCL1) and inflammasome activation in BMDMs.
- In vivo studies using CD14(-/-) mouse air pouches to assess leukocyte influx and IL-1beta induction.
Main Results:
- MSU crystals directly bound sCD14 in vitro.
- CD14(-/-) BMDMs showed reduced IL-1beta and CXCL1 release, with impaired caspase-1 activation and NLRP3 inflammasome activity.
- sCD14 coating restored MSU crystal-induced inflammatory mediator production in CD14(-/-) BMDMs.
- In vivo, CD14(-/-) mice exhibited significantly reduced leukocyte influx and IL-1beta induction in response to MSU crystals.
Conclusions:
- CD14 engagement is a critical determinant of MSU crystal's inflammatory potential.
- CD14 influences MSU crystal recognition and subsequent pro-inflammatory cytokine production.
- Targeting CD14 may offer a therapeutic strategy for gouty inflammation.